| Product Code: ETC10765515 | Publication Date: Apr 2025 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Germany`s import trend for pemetrexed saw a growth rate of 3.83% compared to the previous year. However, the compound annual growth rate (CAGR) for the period 2020-2024 was -1.55%. This decline could be attributed to shifts in demand dynamics or evolving market conditions impacting import momentum.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Germany Pemetrexed Market Overview |
3.1 Germany Country Macro Economic Indicators |
3.2 Germany Pemetrexed Market Revenues & Volume, 2022 & 2032F |
3.3 Germany Pemetrexed Market - Industry Life Cycle |
3.4 Germany Pemetrexed Market - Porter's Five Forces |
3.5 Germany Pemetrexed Market Revenues & Volume Share, By Indication, 2022 & 2032F |
3.6 Germany Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2022 & 2032F |
3.7 Germany Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2022 & 2032F |
3.8 Germany Pemetrexed Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.9 Germany Pemetrexed Market Revenues & Volume Share, By Administration Route, 2022 & 2032F |
4 Germany Pemetrexed Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lung cancer in Germany |
4.2.2 Growing adoption of targeted therapy for cancer treatment |
4.2.3 Government initiatives promoting cancer research and treatment |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High cost associated with pemetrexed treatment |
4.3.3 Limited awareness about pemetrexed therapy among healthcare providers and patients |
5 Germany Pemetrexed Market Trends |
6 Germany Pemetrexed Market, By Types |
6.1 Germany Pemetrexed Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Germany Pemetrexed Market Revenues & Volume, By Indication, 2022 - 2032F |
6.1.3 Germany Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2022 - 2032F |
6.1.4 Germany Pemetrexed Market Revenues & Volume, By Mesothelioma, 2022 - 2032F |
6.1.5 Germany Pemetrexed Market Revenues & Volume, By Breast Cancer, 2022 - 2032F |
6.1.6 Germany Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2022 - 2032F |
6.1.7 Germany Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2022 - 2032F |
6.2 Germany Pemetrexed Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Germany Pemetrexed Market Revenues & Volume, By Antifolate, 2022 - 2032F |
6.2.3 Germany Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2022 - 2032F |
6.2.4 Germany Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2022 - 2032F |
6.2.5 Germany Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2022 - 2032F |
6.2.6 Germany Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2022 - 2032F |
6.3 Germany Pemetrexed Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 Germany Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2022 - 2032F |
6.3.3 Germany Pemetrexed Market Revenues & Volume, By Immunotherapy, 2022 - 2032F |
6.3.4 Germany Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2022 - 2032F |
6.3.5 Germany Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2022 - 2032F |
6.3.6 Germany Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2022 - 2032F |
6.4 Germany Pemetrexed Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Germany Pemetrexed Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Germany Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2022 - 2032F |
6.4.4 Germany Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2022 - 2032F |
6.4.5 Germany Pemetrexed Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
6.4.6 Germany Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2022 - 2032F |
6.5 Germany Pemetrexed Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 Germany Pemetrexed Market Revenues & Volume, By Intravenous, 2022 - 2032F |
6.5.3 Germany Pemetrexed Market Revenues & Volume, By Injection, 2022 - 2032F |
6.5.4 Germany Pemetrexed Market Revenues & Volume, By IV Infusion, 2022 - 2032F |
6.5.5 Germany Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2022 - 2032F |
6.5.6 Germany Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2022 - 2032F |
7 Germany Pemetrexed Market Import-Export Trade Statistics |
7.1 Germany Pemetrexed Market Export to Major Countries |
7.2 Germany Pemetrexed Market Imports from Major Countries |
8 Germany Pemetrexed Market Key Performance Indicators |
8.1 Patient survival rate post pemetrexed treatment |
8.2 Number of clinical trials studying pemetrexed effectiveness |
8.3 Adoption rate of pemetrexed in lung cancer treatment in Germany |
9 Germany Pemetrexed Market - Opportunity Assessment |
9.1 Germany Pemetrexed Market Opportunity Assessment, By Indication, 2022 & 2032F |
9.2 Germany Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2022 & 2032F |
9.3 Germany Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2022 & 2032F |
9.4 Germany Pemetrexed Market Opportunity Assessment, By End User, 2022 & 2032F |
9.5 Germany Pemetrexed Market Opportunity Assessment, By Administration Route, 2022 & 2032F |
10 Germany Pemetrexed Market - Competitive Landscape |
10.1 Germany Pemetrexed Market Revenue Share, By Companies, 2025 |
10.2 Germany Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here